Heart Defect Closure Device Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033 | Abbott Laboratories, Medtronic, Koninklijke Philips N.V., Boston Scientific Corporation, Terumo Corporation, Edwards Lifesciences, W L Gore and As

As per the report, the heart defect closure device market size has grown rapidly in recent years. It will grow from $0.97 billion in 2023 to $1.11 billion in 2024 at a compound annual growth rate (CAGR) of 14.2%. The heart defect closure device market size is expected to see rapid growth in the next few years. It will grow to $1.90 billion in 2028 at a compound annual growth rate (CAGR) of 14.3%.

Download Free Sample Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=16074&type=smp

Congenital Heart Problems Boost Heart Defect Closure Device Market Growth
The growing number of people with congenital heart problems is expected to propel the growth of the heart defect closure device market going forward. Congenital heart problems refer to structural defects in the heart that are present at birth. The increase in congenital heart problems is due to genetic predispositions, environmental influences, and maternal health issues such as diabetes, obesity, and exposure to certain medications or infections during pregnancy. Heart defect closure devices help to treat congenital heart problems by offering minimally invasive solutions to seal abnormal heart openings, thus restoring normal blood flow, reducing complications, and improving overall cardiac function. For instance, in December 2023, according to the data from the Australian Bureau of Statistics 2020-21 National Health Survey, conducted by the Australian Institute of Health and Welfare, an Australia-based government agency, an estimated 571,000 adults aged 18 and over in Australia were living with coronary heart disease (CHD), comprising 2.9% of the adult population. The prevalence of CHD rises significantly with age, impacting approximately 11% of adults aged 75 and above. Therefore, the growing number of people with congenital heart problems is driving the heart defect closure device market.

Innovations In Self-Expanding, Double-Disc Occluders For Heart Defect Closure
Major companies operating in the heart defect closure device market are developing self-expanding, double-disc occluders to provide a minimally invasive solution for sealing heart defects. Self-expanding, double-disc occluders enhance procedural safety, improve patient outcomes by reducing recovery times, and minimize the risk of complications associated with traditional open-heart surgeries. For instance, in September 2022, Abbott Laboratories, a US-based medical devices and health care company launched Amplatzer Talisman PFO Occlusion System in Europe. The Amplatzer Talisman PFO Occlusion System is a medical device designed to close a patent foramen ovale (PFO), an abnormal opening between the left and right atria of the heart that can lead to strokes and other complications. This system uses a minimally invasive procedure to deploy a self-expanding, double-disc occluder made of nitinol wire mesh, effectively sealing the PFO and preventing the passage of clots between the atria.

The heart defect closure device market covered in this report is segmented -

1) By Type: Atrial Septal Defect (ASD) Closure Device, Left Atrial Appendage (LAA) Closure Devices, Patent Foramen Ovale (PFO) Closure Devices, Patent Ductus Arteriosus (PDA) Closure Devices, Ventricular Septal Defect (VSD) Closure Devices
2) By Material: Nitinol-Based Devices, Stainless Steel Devices, Other Materials
3) By Mode Of Delivery: Transcatheter Delivery, Surgical Delivery, Other Modes
4) By End-User: Hospitals, Clinics, Ambulatory Surgical Centers, Other End-Users

Buy Now & Get Exclusive Discount on this Report, Checkout link @
https://www.thebusinessresearchcompany.com/Discount?id=16074&type=discount

Major companies operating in the heart defect closure device market are Abbott Laboratories, Medtronic, Koninklijke Philips N.V., Boston Scientific Corporation, Terumo Corporation, Edwards Lifesciences, W L Gore and Associates, B. Braun, BIOTRONIK SE & Co. KG, Lepu Medical Technology, Meril Life Sciences Pvt. Ltd., MicroPort Scientific Corporation, AtriCure Inc., LifeTech Scientific Corporation, Baylis Medical Company Inc., Biosense Webster Inc., Sahajanand Medical Technologies Limited, Occlutech, Cohere*x Medical Inc., Cardia Inc., Acrostak Corporation, Vivasure Medical, Transmural Systems Inc., Cormatrix Cardiovascular Inc., and St. Jude Medical LLC.

Contents of the report:
1. Executive Summary
2. Heart Defect Closure Device Market Report Structure
3. Heart Defect Closure Device Market Trends And Strategies
4. Heart Defect Closure Device Market - Macro Economic Scenario
5. Heart Defect Closure Device Market Size And Growth
…..
27. Heart Defect Closure Device Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Explore the report store to make a direct purchase of the report @ https://www.thebusinessresearchcompany.com/report/heart-defect-closure-device-global-market-report

Learn More About The Business Research Company

The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.